AI is about to change healthcare. These 7 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
For Elemental Royalty, the big-picture case rests on believing in the resilience of its royalty portfolio and the discipline of its capital allocation, rather than trying to time commodity cycles. The sharp rebound in Q2 net income, alongside the completion of a modest share buyback and the first year of dividends, reinforces a story of a business now generating enough cash to both reinvest and return capital. In the near term, investors are likely to focus on whether recent earnings strength is sustainable given prior dilution, one-off items in the last twelve months and a relatively high price-to-sales multiple. Index inclusions and the expanded credit facility could support future deal flow, but they also raise expectations. The latest results and buyback do not remove the key risks, they just make the trade-off easier to see.
However, investors should be aware that recent earnings include a large non-recurring loss. Elemental Royalty's shares have been on the rise but are still potentially undervalued. Find out how large the opportunity might be.Explore 3 other fair value estimates on Elemental Royalty - why the stock might be worth just CA$32.62!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com